Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Clinical Endocrinology|March 1, 2003
TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patientsI M M J Wakelkamp, O Bakker, L Baldeschi, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|September 8, 1998
Ultrasonographic follow-up of primary choroidal malignant melanoma after proton beam irradiation therapyA Romani, L Baldeschi, F Genovesi-Ebert, et al.
European Journal of Endocrinology|July 23, 2021
The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathyL Bartalena, G J Kahaly, L Baldeschi, et al.
The Journal of Clinical Endocrinology and Metabolism|October 6, 2012
Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathyL Bartalena, G E Krassas, W Wiersinga, et al.
European Journal of Endocrinology|July 27, 2006
A questionnaire survey on the management of Graves' orbitopathy in Europe, P Perros, L Baldeschi, et al.
Journal of Endocrinological Investigation|February 9, 2017
Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?L Bartalena, G Veronesi, G E Krassas, et al.
Orphanet Journal of Rare Diseases|April 22, 2017
Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statementP Perros, L Hegedüs, L Bartalena, et al.
Pageof 3